The KM curves showed that patients with a higher expression of SPP1 had worse OSs in many tumors, including adrenocortical carcinoma, cervical carcinoma, head and neck carcinoma, lower grade glioma, liver hepatocellular carcinoma, and pancreatic cancer (Figure 3E). This evidence concerns the gene SPP1 and adrenal cortex carcinoma.